Rarebase Is on the Hunt for Therapeutic Opportunities (Illumina)
A California company's precision medicine platform studies thousands of rare genetic diseases simultaneously.
Read the full article on the Illumina website:
3,700 disease-causing genes: Our plan to fill the void in rare disease drug discovery
Rarebase Remarks Episode #4 - Clayton Mellina: Engineering and AI in the biotech space
Rarebase launches a neuroscience drug discovery platform collaborating with 15 rare disease patient organizations